Literature DB >> 3421407

Natural cytotoxicity and serum blocking in malignant cervical neoplasia.

M R Pillai1, P Balaram, T Abraham, T K Padmanabhan, M K Nair.   

Abstract

Peripheral blood lymphocytes from 100 patients with various stages and histological types of squamous cell carcinoma of the uterine cervix were assayed for natural killer (NK) cell activity against K562 cells using the single cell cytotoxicity assay in agarose. The effect of autologous serum on NK cell activity and a quantitation of soluble antigen-antibody complexes was also carried out. The cancer patients showed reduced NK activity compared with normal controls, the reduction increasing with tumor load. Another observation was that patients with poorly differentiated tumours showed lower levels of NK activity. Addition of autologous serum resulted in further depression of NK activity in all groups of patients. An increase in circulating immune complexes was also evident in all groups of patients. Here again increase in tumor load and poorly differentiated tumors showed the highest levels. The results point toward a possible disturbance in NK cell activity that could be further depressed by autologous serum factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421407     DOI: 10.1111/j.1600-0897.1988.tb00188.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol Microbiol        ISSN: 8755-8920


  5 in total

1.  In vitro inhibition of natural-killer-mediated lysis by chromatin fragments.

Authors:  A D Le Lann; G J Fournié; L Boissier; P L Toutain; H Benoist
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

2.  Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy.

Authors:  Vino T Cheriyan; Cessal Thomas; Prabha Balaram
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-02       Impact factor: 4.553

3.  Interferon and interleukin-2 induced spontaneous cell-mediated cytotoxicity: a preliminary evaluation.

Authors:  P Balaram; M R Pillai; T Abraham; K R Nalinakumari; G Meenattoor; S Kannan; N K Hareendran; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Immune reactive proteins as prognostic and clinical markers in malignant cervical neoplasia.

Authors:  M Radhakrishna Pillai; P Balaram; N K Hareendran; S Bindu; T Abraham; T K Padmanabhan; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer.

Authors:  S P Bugis; E Lotzová; H E Savage; J P Hester; T Racz; P G Sacks; S P Schantz
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.